Patients with post-ACS depression benefitted from active treatment in clinical trial
A clinical trial of patients with post-acute coronary syndrome (ACS, heart disease) depression finds that a centralized, patient-preference program decreased depressive symptoms and may be cost-neutral over time, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication. The study is being released early to coincide with its presentation at the American College of Cardiology's annual Scientific Sessions.
About 1.2 million Americans survive an ACS event every year and many of them have clinically significant and persistent depression. ...






